{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:32:58Z","timestamp":1790566378453,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>There is increasing interest in the environmental and human damage caused by pollutants. Big efforts are continuously made to monitor their levels and identify safe thresholds. For this purpose, an essential step is to prioritize harmful substances and understand their effect on human body. Perfluorinated compounds (PFCs) deserve particular attention because of their wide diffusion and potential correlation with different diseases including glucose intolerance, hyperlipidaemia, thyroid diseases, gestational diabetes mellitus and hypertension, testicular and genitourinary cancer as well as impaired kidney function. This review focuses on the renal effects of PFCs, with the attempt to clarify their occurrence and pathogenetic mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>We reviewed MEDLINE and EMBASE citations between 31 October 2017 and 31 May 2019 and selected human studies measuring PFCs exposure, kidney function markers and the ability of haemodialysis to remove PFCs from the circulating blood. It has been currently clarified that exposure to PFCs is linked with an impaired kidney function and that they can be removed by blood purification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Further studies are required on the potential synergic negative effect of PFCs co-exposure with other pollutants as well as animal studies about the removal capacity of different haemodialysis membranes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000658","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T01:39:11Z","timestamp":1568425151000},"page":"539-549","source":"Crossref","is-referenced-by-count":23,"title":["Persistent pollutants: focus on perfluorinated compounds and kidney"],"prefix":"10.1097","volume":"25","author":[{"given":"Fiorenza","family":"Ferrari","sequence":"first","affiliation":[{"name":"Anaesthesia and Intensive Care, Emergency Department, Fondazione I.R.C.C.S. Policlinico S. Matteo, Pavia"},{"name":"International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Orlando","sequence":"additional","affiliation":[{"name":"Anaesthesia and Intensive Care, Emergency Department, Fondazione I.R.C.C.S. Policlinico S. Matteo, Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaccaria","family":"Ricci","sequence":"additional","affiliation":[{"name":"International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza"},{"name":"Department of Cardiology and Cardiac Surgery, Paediatric Cardiac Intensive Care Unit, Bambino Ges\u00f9 Children's Hospital, IRCCS, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[{"name":"International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza"},{"name":"Full Professor of Nephrology - University of Padova; Director of Dep. Nephrology Dialysis & Transplant-AUSSL 8 regione Veneto -San bortol Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ieam.258","article-title":"Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins","volume":"7","author":"Buck","year":"2011","journal-title":"Integr Environ Assess Manag"},{"key":"R2-20230913","first-page":"271","article-title":"Fluorinated surfactants in practice","author":"Taylor","year":"1999","journal-title":"Design and selection of performance surfactants: annual surfactants review"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cbi.2005.06.007","article-title":"Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes","volume":"155","author":"Martin","year":"2005","journal-title":"Chem Biol Interact"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/es070895g","article-title":"Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds","volume":"42","author":"Conder","year":"2008","journal-title":"Environ Sci Technol"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tox.2016.11.011","article-title":"Mabury, is there a human health risk associated with indirect exposure to perfluoroalkyl carboxylates (PFCAs)?","volume":"3","author":"Rand","year":"2017","journal-title":"Toxicology"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/toxsci\/kfh302","article-title":"Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys","volume":"82","author":"Butenhoff","year":"2004","journal-title":"Toxicol Sci"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/10473289.2006.10464429","article-title":"Characterizing perfluorooctanoate in ambient air near the fence line of a manufacturing facility: comparing modeled and monitored values","volume":"56","author":"Barton","year":"2006","journal-title":"J Air Waste Manag Assoc"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"e0155190","DOI":"10.1371\/journal.pone.0155190","article-title":"Perfluorooctanesulfonate mediates renal tubular cell apoptosis through ppar gamma inactivation","volume":"11","author":"Wen","year":"2016","journal-title":"PLoS One"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2215\/CJN.04670418","article-title":"Perfluorinated chemicals as emerging environmental threats to kidney health: a scoping review","volume":"13","author":"Stanifer","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12940-015-0077-9","article-title":"Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents","volume":"14","author":"Kataria","year":"2015","journal-title":"Environ Health"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/toxsci\/kfx183","article-title":"From the cover: L-carnitine via PPAR-gamma andSirt1-dependent mechanisms attenuates epithelial-mesenchymal transition and renal fibrosis caused by perfluoroctanesulfonates","volume":"160","author":"Chou","year":"2017","journal-title":"Toxicol Sci"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.reprotox.2011.11.005","article-title":"Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activeted receptors (PPAR) and nuclear receptor-regulated genes in fetal and postanatal CD-1 mouse tissue","volume":"33","author":"Abbott","year":"2012","journal-title":"Reprod Toxicol"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"R15-20230913","first-page":"1042","volume":"220","author":"Wang","year":"2019","journal-title":"Renal function and isomers of perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS): isomers of C8 health project in China\u201d Chemosphere"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.envres.2019.04.034","article-title":"Perfluoroalkyl acids serum concentrations and their relationship to biomarkers of renal failure: Serum and urine albumin, creatinine, and albumin creatinine ratios across the spectrum of glomerular function among US adults","volume":"174","author":"Jain","year":"2019","journal-title":"Environ Res"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.envres.2018.11.033","article-title":"Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: implications for future research","volume":"169","author":"Jain","year":"2019","journal-title":"Environ Res"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1007\/s11356-019-04666-5","article-title":"Dynamics of associations between perfluoroalkyl substances and uric acid across the various stages of glomerular function","volume":"26","author":"Jain","year":"2019","journal-title":"Environ Sci Pollut Res"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.envpol.2018.07.042","article-title":"Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort","volume":"242","author":"Blake","year":"2018","journal-title":"Environ Pollut"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/DMSO.S173809","article-title":"Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes","volume":"11","author":"Conway","year":"2018","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.envres.2018.11.037","article-title":"Synergistic impact of co-exposures to toxic metals cadmium, lead, and mercury along with perfluoroalkyl substances on the healthy kidney function","volume":"169","author":"Jain","year":"2019","journal-title":"Environ Res"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"e0200271","DOI":"10.1371\/journal.pone.0200271","article-title":"Associations between perfluorinated chemicals and serum biochemical markers and performance status in uremic patients under hemodialysis","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3390\/ijerph15112574","article-title":"Dialysis membranes influence perfluorochemical concentrations and liver function in patients on hemodialysis","volume":"15","author":"Liu","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.envint.2017.10.026","article-title":"Biomonitoring of perfluorinated compounds in adults exposed to contaminated drinking water in the Veneto Region, Italy","volume":"110","author":"Ingelido","year":"2018","journal-title":"Environ Int"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1021\/acs.est.9b01608","article-title":"Mass spectrometry-based metabolomics reveals occupational exposure to per- and polyfluoroalkyl substances relates to oxidative stress, fatty acid \u03b2-oxidation disorder, and kidney injury in a manufactory in China","volume":"53","author":"Lu","year":"2019","journal-title":"Environ Sci Technol"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/tx200363w","article-title":"Renal elimination of perfluorocarboxylates (PFCAs)","volume":"25","author":"Han","year":"2012","journal-title":"Chem Res Toxicol"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40572-018-0194-z","article-title":"Breastfeeding as a predictor of serum concentrations of per- and polyfluorinated alkyl substances in reproductive-aged women and young children: a rapid systematic review","volume":"5","author":"Van Noy","year":"2018","journal-title":"Curr Environ Health Rep"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1532-0456(03)00043-7","article-title":"Alterations in cell membrane properties caused by perfluorinated compounds","volume":"135","author":"Hu","year":"2003","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4062\/biomolther.2012.20.3.268","article-title":"Drug-induced nephrotoxicity and its biomarkers","volume":"20","author":"Kim","year":"2012","journal-title":"Biomol Ther"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/japtr.JAPTR_336_18","article-title":"Nephrotoxicity: role and significance of renal biomarkers in the early detection of acute renal injury","volume":"10","author":"Al-Naimi","year":"2019","journal-title":"J Adv Pharm Technol Res"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/15563650.2012.683436","article-title":"The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology","volume":"50","author":"Lavergne","year":"2012","journal-title":"Clin Toxicol (Phila)"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:37:10Z","timestamp":1694619430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000658","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}